Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males

Clinical trial NCT06542237 · RECRUITING

Trial details

NCT number: NCT06542237
Sponsor: YourChoice Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Male Contraception

Start date: 2024-09-11
Primary completion: 2026-07-31
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.